Repron Therapeutics

Milano, Italy

Repron provides treatments for solid tumour cases where radical excision is not possible and metastasis or recurrence is extremely likely.

$2.1M raised

Jun 2023

Seed

Biotechnology Health Care

Top Investors

Claris Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Repron Therapeutics

How much funding has Repron Therapeutics raised?

Repron Therapeutics has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in June 2023.

Who are Repron Therapeutics's investors?

Repron Therapeutics's investors include Claris Ventures.

Where is Repron Therapeutics headquartered?

Repron Therapeutics is headquartered in Milano, Italy.

What does Repron Therapeutics do?

Repron provides treatments for solid tumour cases where radical excision is not possible and metastasis or recurrence is extremely likely.

What stage is Repron Therapeutics at?

Repron Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2023.

MLA

"Repron Therapeutics — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/repron-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Repron Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/repron-therapeutics

Wikipedia (cite web)

{{cite web |title=Repron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/repron-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K